Study to Assess the Safety and Pharmacokinetics of WP1122 in Healthy Volunteers
Clinical trial NCT05195723 · COMPLETED
Trial details
- NCT number
- NCT05195723
- Sponsor
- Moleculin Biotech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-11
- Primary completion
- 2022-10-24
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.